- Home
- DNLI vs WT Comparison
DNLI vs WT Comparison
Compare DNLI & WT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | DNLI | WT |
|---|---|---|
| Founded | 2013 | 1985 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Investment Bankers/Brokers/Service |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.7B | 3.0B |
| IPO Year | 2017 | 2011 |
Fundamental Metrics
Financial Performance| Metric | DNLI | WT |
|---|---|---|
| Price | $23.27 | $24.46 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 14 | 3 |
| Target Price | ★ $34.33 | $17.67 |
| AVG Volume (30 Days) | 1.2M | ★ 2.5M |
| Earning Date | 05-06-2026 | 05-01-2026 |
| Dividend Yield | N/A | ★ 0.74% |
| EPS Growth | N/A | ★ 127.27 |
| EPS | N/A | ★ 0.14 |
| Revenue | N/A | ★ $493,753,000.00 |
| Revenue This Year | N/A | $35.04 |
| Revenue Next Year | $408.85 | $8.68 |
| P/E Ratio | ★ N/A | $171.86 |
| Revenue Growth | N/A | ★ 15.43 |
| 52 Week Low | $12.58 | $10.69 |
| 52 Week High | $27.30 | $25.89 |
Technical Indicators
Market Signals| Indicator | DNLI | WT |
|---|---|---|
| Relative Strength Index (RSI) | 41.67 | 67.87 |
| Support Level | $22.32 | $16.06 |
| Resistance Level | $23.62 | N/A |
| Average True Range (ATR) | 0.76 | 0.77 |
| MACD | -0.18 | 0.03 |
| Stochastic Oscillator | 8.33 | 63.40 |
Price Performance
Historical ComparisonAbout DNLI Denali Therapeutics Inc.
Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegenerative diseases. The company's development programs include the LRRK2 Inhibitor Program, which develops brain penetrant small molecule LRRK2 inhibitor product candidates for Parkinson's disease. Its key products include DNL201, DNL151, ATV (Antibody Transport Vehicle), ETV (Enzyme Transport Vehicle), and others. The Company has one operating segment with the goal to discover, develop, and commercializing therapeutics.
About WT WisdomTree Inc.
WisdomTree Inc is a financial innovator, offering a diverse suite of Exchange-traded products (ETPs), models and solutions, private market investments and digital asset-related products. It also offers digital products and services related to tokenized real world assets and stablecoins, including tokenized mutual funds (Digital Funds), as well as its institutional platform, WisdomTree Connect, and blockchain-native digital wallet, WisdomTree Prime. The company's products are distributed across various asset management industry channels, including banks, brokerage firms, registered investment advisers, institutional investors, private wealth managers and online brokers. The majority of the company's revenue is generated from advisory fees earned from ETPs.